Shanzhi Li
No. 1035, Boshuo Road
Changchun, 130117, China
Changchun, 130117, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Corylin inhibits liver cancer cell growth through the endogenous apoptosis and mitophagy.
Journal: Translational cancer research
Published: November 19, 2025
Construction, screening and immunogenicity of the recombinant poxvirus vaccine rVTTδTK-RBD against SARS-CoV-2
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: January 21, 2024
Peimisine ameliorates DSS-induced colitis by suppressing Jak-Stat activation and alleviating gut microbiota dysbiosis in mice.
Journal: The Journal of pharmacy and pharmacology
Published: February 04, 2023
Human adenovirus type 7 subunit vaccine induces dendritic cell maturation through the TLR4/NF-κB pathway is highly immunogenic.
Journal: Frontiers in cellular and infection microbiology
Published: December 06, 2022
Inhibitory Effects of Esculetin on Liver Cancer Through Triggering NCOA4 Pathway-Mediation Ferritinophagy in vivo and in vitro.
Journal: Journal of hepatocellular carcinoma
Published: November 08, 2022
Caryophyllene Oxide Induces Ferritinophagy by Regulating the NCOA4/FTH1/LC3 Pathway in Hepatocellular Carcinoma.
Journal: Frontiers in pharmacology
Published: May 10, 2022
Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo.
Journal: Cancer management and research
Published: May 04, 2022
A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells.
Journal: Journal of cellular and molecular medicine
Published: April 18, 2022
Apoptin mediates mitophagy and endogenous apoptosis by regulating the level of ROS in hepatocellular carcinoma.
Journal: Cell communication and signaling : CCS
Published: December 16, 2021
In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide.
Journal: Journal of cancer research and clinical oncology
Published: September 09, 2021
Last Updated: 09/26/2026